Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 25

Publication Record

Connections

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.
Huang J, Nair SG, Mahoney MR, Nelson GD, Shields AF, Chan E, Goldberg RM, Gill S, Kahlenberg MS, Quesenberry JT, Thibodeau SN, Smyrk TC, Grothey A, Sinicrope FA, Webb TA, Farr GH, Pockaj BA, Berenberg JL, Mooney M, Sargent DJ, Alberts SR, Alliance for Clinical Trials in Oncology
(2014) Clin Colorectal Cancer 13: 100-9
MeSH Terms: Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Cetuximab, Chemotherapy, Adjuvant, Colonic Neoplasms, Disease-Free Survival, Female, Fluorouracil, Follow-Up Studies, Humans, Leucovorin, Male, Middle Aged, Mutation, Neoplasm Staging, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Survival Rate, Treatment Outcome, ras Proteins
Added March 28, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms
Beyond exon 2--the developing story of RAS mutations in colorectal cancer.
Berlin J
(2013) N Engl J Med 369: 1059-60
MeSH Terms: Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms, ErbB Receptors, Fluorouracil, Genes, ras, Humans, Leucovorin, Organoplatinum Compounds, Panitumumab, Proto-Oncogene Proteins, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins p21(ras), ras Proteins
Added March 20, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Aflibercept.
Ciombor KK, Berlin J, Chan E
(2013) Clin Cancer Res 19: 1920-5
MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Colorectal Neoplasms, Disease-Free Survival, Fluorouracil, Humans, Irinotecan, Leucovorin, Neoplasm Metastasis, Organoplatinum Compounds, Oxaliplatin, Placenta Growth Factor, Pregnancy Proteins, Protein Binding, Randomized Controlled Trials as Topic, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Treatment Outcome, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor B
Added September 10, 2013
0 Communities
4 Members
0 Resources
22 MeSH Terms
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer.
Berlin J, Bendell JC, Hart LL, Firdaus I, Gore I, Hermann RC, Mulcahy MF, Zalupski MM, Mackey HM, Yauch RL, Graham RA, Bray GL, Low JA
(2013) Clin Cancer Res 19: 258-67
MeSH Terms: Adult, Aged, Aged, 80 and over, Anilides, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Camptothecin, Colorectal Neoplasms, Female, Fluorouracil, Humans, Leucovorin, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Metastasis, Organoplatinum Compounds, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Pyridines, Treatment Outcome, ras Proteins
Added March 7, 2014
0 Communities
1 Members
0 Resources
23 MeSH Terms
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer.
Berlin J, Posey J, Tchekmedyian S, Hu E, Chan D, Malik I, Yang L, Amado RG, Hecht JR
(2007) Clin Colorectal Cancer 6: 427-32
MeSH Terms: Adenocarcinoma, Adult, Aged, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Colorectal Neoplasms, ErbB Receptors, Female, Fluorouracil, Humans, Irinotecan, Leucovorin, Male, Middle Aged, Neoplasm Metastasis, Panitumumab, Vitamin B Complex
Added March 20, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B
(2007) Int J Radiat Oncol Biol Phys 67: 397-404
MeSH Terms: Adenocarcinoma, Adolescent, Adult, Aged, Analysis of Variance, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Cisplatin, Drug Administration Schedule, Esophageal Neoplasms, Esophagectomy, Feasibility Studies, Female, Fluorouracil, Humans, Leucovorin, Male, Middle Aged, Neoadjuvant Therapy, Paclitaxel, Radiotherapy Dosage
Added May 3, 2013
0 Communities
2 Members
0 Resources
21 MeSH Terms
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.
Lockhart AC, Cropp GF, Berlin JD, Donnelly E, Schumaker RD, Schaaf LJ, Hande KR, Fleischer AC, Hannah AL, Rothenberg ML
(2006) Am J Clin Oncol 29: 109-15
MeSH Terms: Aged, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Colorectal Neoplasms, Drug Administration Schedule, Female, Fluorouracil, Humans, Indoles, Infusions, Intravenous, Injections, Intravenous, Irinotecan, Leucovorin, Male, Middle Aged, Neoplasm Metastasis, Pyrroles, Vascular Endothelial Growth Factor Receptor-2
Added February 28, 2014
0 Communities
3 Members
0 Resources
18 MeSH Terms
A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma.
Morgan-Meadows S, Mulkerin D, Berlin JD, Kim K, Bailey H, Saphner T, Jumonville A, Hansen R, Ahuja H, McFarland T, Thomas JP
(2005) Oncology 69: 130-4
MeSH Terms: Adenocarcinoma, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Deoxycytidine, Drug Administration Schedule, Esophageal Neoplasms, Female, Fluorouracil, Humans, Infusions, Intravenous, Injections, Intravenous, Leucovorin, Male, Middle Aged, Neoplasm Metastasis, Survival Analysis, Treatment Outcome
Added March 20, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F
(2005) J Clin Oncol 23: 3502-8
MeSH Terms: Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Colorectal Neoplasms, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Fluorouracil, Humans, Leucovorin, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Staging, Probability, Prognosis, Risk Assessment, Survival Analysis, Treatment Outcome
Added March 20, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Tedesco KL, Berlin J, Blanke CD, Teng M, Choy H, Roberts J, Beauchamp RD, Leach S, Wyman K, Tarpley J, Shyr Y, Caillouette C, Chakravarthy B
(2005) Int J Radiat Oncol Biol Phys 61: 1364-70
MeSH Terms: Adenocarcinoma, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Squamous Cell, Cisplatin, Combined Modality Therapy, Drug Combinations, Esophageal Neoplasms, Female, Humans, Leucovorin, Male, Middle Aged, Radiation-Sensitizing Agents, Tegafur, Uracil
Added May 3, 2013
0 Communities
2 Members
0 Resources
16 MeSH Terms